ATIM-30. PHASE 1B OPEN-LABEL RANDOMIZED STUDY OF THE ONCOLYTIC VIRUS DNX-2401 ADMINISTERED WITH OR WITHOUT INTERFERON GAMMA FOR RECURRENT GLIOBLASTOMA
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.